Rebecca Rohlfs

Statistics

Publications

Citations

171

H-Index

Active since

2021

Affiliations

Novo Nordisk (United States)(Current)

University of Cincinnati

Helmholtz Zentrum München

Novo Nordisk (Denmark)

Indiana University Bloomington

Rebecca Rohlfs is an author at Novo Nordisk (United States) specializing in molecular pharmacology, pharmacology, and g protein-coupled receptor signaling.

Publications per year

2021–2025

Publications

GLP-1-directed NMDA receptor antagonism for obesity treatment

Jonas Petersen, Mette Q. Ludwig, Vaida Juozaityte et al. · Nature · 2024 · 85 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems

Bin Yang, Vasily M. Gelfanov, Kimberley El et al. · Molecular Metabolism · 2022 · 48 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Optimization of Truncated Glucagon Peptides to Achieve Selective, High Potency, Full Antagonists

Bin Yang, Vasily M. Gelfanov, Diego Pérez–Tilve et al. · Journal of Medicinal Chemistry · 2021 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice

Jonathan D. Douros, Aaron Novikoff, Barent DuBois et al. · Molecular Metabolism · 2025 · 16 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

1–4 of 4